Bruehlman Ronald E — SEC Form 4 filings
SEC reporting owner CIK 1604076. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-08 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IQVIA HOLDINGS INC. (IQV) | See Remarks | 5 | — | — | 11 |
| GoodRx Holdings, Inc. (GDRX) | Director | 7 | — | — | 10 |
Form 4 filings — Bruehlman Ronald E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | GoodRx Holdings, Inc. (GDRX) | Grant/award (A): 73,434 @ $0 | EDGAR |
| 2026-05-29 | 4 | GoodRx Holdings, Inc. (GDRX) | Grant/award (A): 4,642 @ $0 | EDGAR |
| 2026-02-10 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 16,335 @ $0 · Tax withholding (F): 6,801 @ $187.49 | EDGAR |
| 2026-01-05 | 4 | GoodRx Holdings, Inc. (GDRX) | Grant/award (A): 18,251 @ $0 | EDGAR |
| 2025-11-10 | 4 | GoodRx Holdings, Inc. (GDRX) | Option exercise (M): 21,691 · Option exercise (M): 21,691 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | GoodRx Holdings, Inc. (GDRX) | Grant/award (A): 57,050 @ $0 | EDGAR |
| 2025-02-12 | 4 | IQVIA HOLDINGS INC. (IQV) | Tax withholding (F): 907 @ $206.97 | EDGAR |
| 2025-01-30 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 6,286 @ $0 · Tax withholding (F): 2,201 @ $203.43 · Grant/award (A): 31,603 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | GoodRx Holdings, Inc. (GDRX) | Grant/award (A): 10,653 @ $0 | EDGAR |
| 2024-11-12 | 4 | GoodRx Holdings, Inc. (GDRX) | Grant/award (A): 1,128 @ $0 · Grant/award (A): 20,503 @ $0 · Grant/award (A): 65,075 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | IQVIA HOLDINGS INC. (IQV) | Tax withholding (F): 1,033 @ $218.20 · Tax withholding (F): 907 @ $218.20 | EDGAR |
| 2024-02-08 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 24,141 @ $0 · Tax withholding (F): 10,514 @ $215.41 · Grant/award (A): 20,719 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1604076 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →